191 related articles for article (PubMed ID: 38399293)
1. Editorial for Special Issue: "Liposomal and Lipid-Based Drug Delivery Systems and Vaccines".
Vodovozova EL
Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399293
[TBL] [Abstract][Full Text] [Related]
2. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
3. Developments in liposomal drug delivery systems.
Maurer N; Fenske DB; Cullis PR
Expert Opin Biol Ther; 2001 Nov; 1(6):923-47. PubMed ID: 11728226
[TBL] [Abstract][Full Text] [Related]
4. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.
Watson DS; Endsley AN; Huang L
Vaccine; 2012 Mar; 30(13):2256-72. PubMed ID: 22306376
[TBL] [Abstract][Full Text] [Related]
5. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
[TBL] [Abstract][Full Text] [Related]
6. Liposomal adjuvants for human vaccines.
Alving CR; Beck Z; Matyas GR; Rao M
Expert Opin Drug Deliv; 2016 Jun; 13(6):807-16. PubMed ID: 26866300
[TBL] [Abstract][Full Text] [Related]
7. Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'.
Akhtar N; Khan RA
Prog Lipid Res; 2016 Oct; 64():192-230. PubMed ID: 27697511
[TBL] [Abstract][Full Text] [Related]
8. Liposomal drug delivery systems: an update review.
Samad A; Sultana Y; Aqil M
Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
[TBL] [Abstract][Full Text] [Related]
9. Liposomes as Adjuvants and Vaccine Delivery Systems.
Tretiakova DS; Vodovozova EL
Biochem (Mosc) Suppl Ser A Membr Cell Biol; 2022; 16(1):1-20. PubMed ID: 35194485
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
Ranade VV
J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
[TBL] [Abstract][Full Text] [Related]
11. Photo-triggerable liposomal drug delivery systems: from simple porphyrin insertion in the lipid bilayer towards supramolecular assemblies of lipid-porphyrin conjugates.
Massiot J; Rosilio V; Makky A
J Mater Chem B; 2019 Mar; 7(11):1805-1823. PubMed ID: 32255044
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
Zylberberg C; Matosevic S
Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Lipid Types and Liposomal Formulations on Osteoblast Adiposity and Mineralization.
Chang SF; Yeh CC; Chen PJ; Chang HI
Molecules; 2018 Jan; 23(1):. PubMed ID: 29301300
[TBL] [Abstract][Full Text] [Related]
14. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
15. Insights into Asymmetric Liposomes as a Potential Intervention for Drug Delivery Including Pulmonary Nanotherapeutics.
Al Badri YN; Chaw CS; Elkordy AA
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678922
[TBL] [Abstract][Full Text] [Related]
16. Use of liposomes as injectable-drug delivery systems.
Ostro MJ; Cullis PR
Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
[TBL] [Abstract][Full Text] [Related]
17. Peptide-labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells.
Morisco A; Accardo A; Tesauro D; Palumbo R; Benedetti E; Morelli G
Biopolymers; 2011; 96(1):88-96. PubMed ID: 20560147
[TBL] [Abstract][Full Text] [Related]
18. Liposomes in the treatment of malignancy: a clinical perspective.
Sugarman SM; Perez-Soler R
Crit Rev Oncol Hematol; 1992; 12(3):231-42. PubMed ID: 1497823
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tetraether lipid-based liposomal carriers for encapsulation and retention of nucleoside-based drugs.
Paolucci V; Leriche G; Koyanagi T; Yang J
Bioorg Med Chem Lett; 2017 Sep; 27(18):4319-4322. PubMed ID: 28838688
[TBL] [Abstract][Full Text] [Related]
20. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
Richards RL; Alving CR; Wassef NM
J Pharm Sci; 1996 Dec; 85(12):1286-9. PubMed ID: 8961140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
